- Generic name
- Rifampicin
- Strength
- 150 mg
- Dosage form
- Capsule
- Manufactured by
- KDH Laboratories Ltd.
Refam Capsule
About Refam 150 mg Capsule
Refam 150 mg Capsule is an antibiotic used mainly in tuberculosis treatment. It works by blocking a key step in bacterial RNA production, which stops susceptible bacteria from multiplying.
There are 18 brands of Rifampicin listed in Bangladesh. The lowest listed price is Firifam 150 mg Tablet at ৳ 1 per unit.
What is Refam 150 mg Capsule?
Refam 150 mg Capsule is an anti-tubercular antibiotic. Its active ingredient, rifampicin, binds to a bacterial enzyme needed for RNA synthesis, thereby blocking RNA transcription and stopping bacterial growth. Doctors prescribe it as part of combination therapy for tuberculosis and for meningococcal carrier states. Because resistant bacteria can quickly dominate, laboratory testing before treatment helps confirm susceptibility. This medicine may interact with many other drugs and can affect liver function, so tell your doctor about all medicines you take and any liver problems. Always use it under medical supervision.
Uses of Refam
Refam 150 mg Capsule is used in the treatment of tuberculosis, usually alongside other anti-tubercular medicines. It is also used for the meningococcal carrier state. Rifampicin belongs to the rifamycin group of antibiotics. It is not a treatment for viral infections. Your doctor will decide whether this medicine is appropriate for your condition based on tests and clinical assessment.
How to use Refam
Take Refam 150 mg Capsule exactly as your doctor prescribes. The doctor decides the dose, frequency, and duration of treatment. Swallow the capsule with a full glass of water. It is usually recommended to take oral rifampicin once daily, either one hour before or two hours after a meal. Do not stop or change the schedule without medical advice. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Refam
Common side effects include facial flushing and itching, with or without a rash, and flu-like symptoms such as fever, chills, headache, dizziness, bone pain, and shortness of breath. Gastrointestinal effects like nausea, vomiting, loss of appetite, and diarrhoea may occur. Rifampicin commonly causes orange-red discolouration of urine, faeces, sweat, saliva, sputum, and tears. Other effects include changes in kidney function, menstrual disturbances, and muscle weakness. Rarely, eye irritation may occur. Contact your doctor if side effects are troublesome.
Safety and precautions
Do not take Refam 150 mg Capsule if you have a history of allergy to rifampicin or other rifamycins. It must not be used with ritonavir-boosted saquinavir or with atazanavir, darunavir, fosamprenavir, saquinavir, or tiprenavir due to serious risks. Rifampicin can cause liver dysfunction; patients with liver impairment should use it only if necessary and under strict medical supervision, with liver function monitoring. It may interact with many medicines, including antacids, ketoconazole, phenytoin, and halothane. In late pregnancy, it can cause bleeding in mother and infant. Breastfeeding decisions should be made with the doctor.
Frequently asked questions
What is Refam 150 mg Capsule used for and what kind of medicine is it?
Refam 150 mg Capsule is an antibiotic containing rifampicin, used in the treatment of tuberculosis and the meningococcal carrier state. It belongs to the anti-tubercular antibiotics class. It is usually given as part of a combination regimen. Your doctor will determine if it is suitable for your condition.
How should Refam 150 mg Capsule be taken?
Take it exactly as your doctor prescribes. Swallow the capsule with a full glass of water. Oral rifampicin is usually taken once daily, either one hour before or two hours after a meal. The doctor decides the dose and how long you need to take it. Do not stop treatment without medical advice.
Who should avoid Refam 150 mg Capsule or ask the doctor first?
People allergic to rifampicin or other rifamycins should not take it. It is also contraindicated with certain antiviral medicines such as ritonavir-boosted saquinavir, atazanavir, darunavir, fosamprenavir, saquinavir, and tipranavir. Those with liver problems, pregnant or breastfeeding women, and anyone taking other medicines should consult the doctor first.
What should I know about side effects and interactions of Refam 150 mg Capsule?
It may cause orange-red discolouration of body fluids, flu-like symptoms, and stomach upset. Serious liver problems can occur, especially with other liver-toxic drugs. It interacts with many medicines, including antacids, ketoconazole, phenytoin, and halothane. Tell your doctor about all medicines you take and report any unusual symptoms promptly.
Indications
Pharmacology
Dosage & Administration
Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
Interaction
Contraindications
Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
Side Effects
Pregnancy & Lactation
Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Precautions & Warnings
In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
Overdose Effects
Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
Storage Conditions
Alternative brands of Rifampicin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.